Trials / Unknown
UnknownNCT01301261
Sugammadex: Effect on the Awareness Monitoring and Hemodynamics
The Effect of Sugammadex on Hemodynamics, Oxygenation, End-tidal CO2, Entropy and Bispectral Index Intraoperatively Without Steroid Neuromuscular Blocker
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- University of Athens · Academic / Other
- Sex
- All
- Age
- 30 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Sugammadex is used to reverse the neuromuscular blocking effect of steroid neuromuscular blockers. Its cardiovascular effects and effect on brain cortex, if any, may be associated to the reversal of the neuromuscular block. The aim of the study was to investigate the pure effects of sugammadex in the absence of the agonist.
Detailed description
Three groups of patients undergoing elective major surgery and given cis-atracurium for muscle relaxation are studied. Group 1 receives 2 mg/kg of sugammadex when a count of two of the train of four appears Group 2 receives 4 mg/kg of sugammadex when a posttetanic count 1-3 appears Group 3 receives 16 mg/kg of sugammadex three minutes after administration of cis-atracurium. Heart rate, arterial blood pressure, oxygen saturation, end-tidal CO2, entropy and bispectral index are recorded every three minutes
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | sugammadex | Sugammadex 2 mg/kg when a two count of train of four appears |
| DRUG | Sugammadex 4 mg/kg | Sugammadex 4 mg/kg are given when a posttetanic count 1-3 appears |
| DRUG | Sugammadex 16mg/kg | Sugammadex 16 mg/kg three minutes after the injection of cis-atracurium |
Timeline
- Start date
- 2010-12-01
- Primary completion
- 2013-02-01
- First posted
- 2011-02-23
- Last updated
- 2012-06-19
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT01301261. Inclusion in this directory is not an endorsement.